View highlights and coverage from leading international Ophthalmology congresses
Conference Hub Content
Thomas V Johnson, AGS 2021: Current Status and Future Challenges of Stem Cell-based Retinal Ganglion Cell Transplantation in Glaucoma Therapy
We were delighted to speak with Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) and find out his thoughts on the current status and future challenges of stem cell-based retinal ganglion cell transplantation in glaucoma therapy, and the challenges and opportunities of the online format of this year’s virtual meeting. […]
Thomas V Johnson, AGS 2021: Cell Intrinsic and Microenvironmental Modulators of Human Stem Cell Derived RGC Survival and Retinal Integration Following Transplantation
It was a pleasure to speak to Dr Thomas V Johnson (Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA) about his presentation at AGS 2021, investigating cell intrinsic and microenvironmental modulators of retinal ganglion cell survival and retinal integration following transplantation. Questions What were the aims and design of your study investigating cell intrinsic […]
Qi Cui, AGS 2021: Promising Novel Therapies in Glaucoma and Meeting Highlights
It was great to speak with Dr Qi Cui (Scheie Eye Institute, University of Pennsylvania, PA, USA) about her views on the most promising novel therapies targeting risk factors other than intraocular pressure in glaucoma, and her highlights from AGS21. Questions What are the most promising novel therapies targeting risk factors other than intraocular pressure […]
Qi Cui, AGS 2021: The GLP-1R Agonist NLY01 Reduces Neuroinflammation and Protects against RGC Loss in a Preclinical Glaucoma Model
We were delighted to catch up with Dr Qi Cui (Scheie Eye Institute, University of Pennsylvania, PA, USA), who told us about her research on the GLP-1R agonist NLY01 and the next steps for clinical development. Questions What is NLY01 and what is the rationale for its use in glaucoma therapy? (00:20) Could you give […]
David Huang, AGS 2021: Predictive Value of Baseline Visual Field, Disc, and Optical Coherence Tomography Diagnoses on Subsequent Glaucoma Progression
It was a pleasure to speak with Prof. David Huang (OHSU Casey Eye Institute, Portland, OR, USA) about his presentation at AGS 2021 on the predictive value of baseline visual field, disc and optical coherence tomography diagnoses on subsequent glaucoma progression. Questions Prior to your study, what was already known about the ability of baseline […]
Full- or Partial-thickness Sutures for Penetrating Corneal Wound?
Eye trauma has always been part of ophthalmologist’s everyday practice. The most common form of open-globe trauma is the corneal laceration. Unfortunately, the treatment of these lesions has been seeped in tradition. At the dawn of the 20th century, the management of these wounds involved the use of a conjuctival flap to cover them, since […]
Jorge L Alió, EGS 2020 – Innovations in Premium IOLs
We caught up with Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) to find out the most promising recent advances in premium IOLs. Questions Could you give us a brief overview of your experience with premium IOLs? (0:05) What are the most promising recent advances and what issues with premium IOLs remain to […]
Jorge L Alió, EGS 2020 – Corneal Regeneration, Will It Be a Reality in 2021?
We were delighted to talk with our Editorial Board member, Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) about the recent technological advances in corneal regeneration. Questions Could you tell us a little about the challenges and opportunities of corneal regeneration? (0:05) What have been the most exciting recent technological advances in corneal […]
Cynthia Matossian, AAO 2020 – Outcomes With Dexamethasone Intraocular Suspension 9% and Concomitant Postoperative Anti-inflammatory Medications
It was a huge pleasure to catch up with our esteemed Editorial Board member, Cynthia Matossian (Matossian Eye Associates, Hopewell and Hamilton, NJ, USA), as she talked us through her AAO presentation on outcomes with dexamethasone intraocular suspension 9% and concomitant postoperative anti-inflammatory medications. Questions What is the rationale for the use of dexamethasone intraocular […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!